FDA docs give Moderna green light, while spotlighting differences with Pfizer
The US looks set to go from zero to two Covid-19 vaccines in a week.
On Tuesday, the FDA released its in-house assessment of Moderna’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
